These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 24919370

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Immune thrombocytopenic purpura: pathophysiology and treatment].
    Godeau B.
    Transfus Clin Biol; 2009 May; 16(2):101-5. PubMed ID: 19409827
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Current treatment of primary immune thrombocytopenia].
    Lozano ML, Vicente V.
    Med Clin (Barc); 2014 May 06; 142(9):399-405. PubMed ID: 23809409
    [Abstract] [Full Text] [Related]

  • 7. [New treatment options for primary immune thrombocytopenia].
    Gudbrandsdottir S, Frederiksen H, Birgens HS, Nielsen CH, Nielsen OJ, Stentoft J, Hasselbalch HC.
    Ugeskr Laeger; 2011 Jan 24; 173(4):271-4. PubMed ID: 21262171
    [Abstract] [Full Text] [Related]

  • 8. Immune thrombocytopenia in adults: an update.
    Thota S, Kistangari G, Daw H, Spiro T.
    Cleve Clin J Med; 2012 Sep 24; 79(9):641-50. PubMed ID: 22949345
    [Abstract] [Full Text] [Related]

  • 9. [Immune thrombocytopenia--pathophysiology and treatment].
    Ghanima W, Holme PA, Tjønnfjord GE.
    Tidsskr Nor Laegeforen; 2010 Nov 04; 130(21):2120-3. PubMed ID: 21052113
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
    Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S.
    Thromb Haemost; 2008 Jan 04; 99(1):4-13. PubMed ID: 18217129
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D.
    Hematology; 2012 Apr 04; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [Abstract] [Full Text] [Related]

  • 17. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F.
    Eur J Haematol Suppl; 2008 Feb 04; (69):19-26. PubMed ID: 18211569
    [Abstract] [Full Text] [Related]

  • 18. Multiple cycles of rituximab therapy in chronic refractory immune thrombocytopenia: a case report with a 10-year follow-up.
    Routy B, Boulassel MR, Spurll GM, Warner MN, Routy JP.
    Am J Ther; 2013 Feb 04; 20(2):219-22. PubMed ID: 23466621
    [Abstract] [Full Text] [Related]

  • 19. [Recurrent infections in an ITP patient treated with rituximab].
    Rosenberg-Bezalel S, Asher I, Sthoeger Z.
    Harefuah; 2012 Nov 04; 151(11):617-9, 655. PubMed ID: 23367730
    [Abstract] [Full Text] [Related]

  • 20. Immune thrombocytopenia: no longer 'idiopathic'.
    McCrae K.
    Cleve Clin J Med; 2011 Jun 04; 78(6):358-73. PubMed ID: 21632906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.